Halozyme Therapeutics, Inc. (NASDAQ:HALO)
| CAPS Rating |
|
|---|---|
| Open | $10.61 |
| Previous Close | $11.11 |
| Daily Range | $10.61 - $11.24 |
| 52-Week Range | $5.54 - $11.62 |
| Market Cap | $1.15B |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 3,825,076 |
| Average Daily Volume | 0 |
HALO
VS S&P 500 (SPY)
How do you think HALO will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
HALO Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
HALO News and Commentary
- Update on VPHM's Industrial Facility - Analyst Blog – NASDAQ
- Zacks.com featured expert Kevin Matras highlights: Brookfield Office Properties Inc., Fiserv, Inc., – NASDAQ
- Priority Review for VPHM's Drug - Analyst Blog – NASDAQ
- 3 Stocks Near 52-Week Highs Worth Selling – The Motley Fool
- ViroPharma's Seizure Drug Reaches UK - Analyst Blog – NASDAQ
- ViroPharma-Halozyme Drug Advances - Analyst Blog – NASDAQ
- Halozyme Therapeutics Shares Popped: What You Need to Know – The Motley Fool
- Value Ideas: Top 10 Options Market Picks Trading Well Below Target Price – NASDAQ
- Value Ideas: Top 10 Options Market Picks Trading Well Below Target Price – The Motley Fool
- 5 of Last Week's Biggest Winners – The Motley Fool
- Halozyme Therapeutics Shares Surged: What You Need to Know – The Motley Fool
- You're Not the Only One Buying Here – The Motley Fool
- The Fastest-Growing Biotech Stocks – The Motley Fool
- Shire Enters a Crowded Market – The Motley Fool
- 12 Biotech Stocks the Insiders Are Buying – The Motley Fool
- Halozyme Therapeutics Shares Popped: What You Need to Know – The Motley Fool
- Amylin, MannKind Shares Rise On Diabetes Data Releases – SmartMoney
- ViroPharma Gives It a Shot – The Motley Fool
- 14 Companies Near Lows With Enough Cash to Cover More Than a Year's Expenses – SeekingAlpha
- Value Traps? Top 19 Most Undervalued Stocks Near 52-Week Lows – SeekingAlpha
RSS Headlines
Fool UK
